| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2373827C Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 09/16/2008 | CA2331414C Transdermal therapeutic system for the administration of candesartan |
| 09/16/2008 | CA2295483C Aliphatic propargylamines as cellular rescue agents |
| 09/16/2008 | CA2294095C Synergistically acting compositions for selectively combating tumor tissue |
| 09/16/2008 | CA2223910C Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 09/12/2008 | WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/12/2008 | WO2008108445A1 Benzoxazepine derivatives and use thereof |
| 09/12/2008 | WO2008108386A1 Pharmaceutical composition |
| 09/12/2008 | WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell |
| 09/12/2008 | WO2008108284A1 Rankl production inhibitor |
| 09/12/2008 | WO2008108209A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
| 09/12/2008 | WO2008079677A3 Polymer encapsulation and/or binding |
| 09/12/2008 | CA2680161A1 Pharmaceutical composition |
| 09/12/2008 | CA2679924A1 Milk-derived basic protein fraction for inhibiting rankl production |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221207 Use of specific cyklolignans |
| 09/11/2008 | US20080221192 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems |
| 09/11/2008 | US20080221184 angiotensin II antagonist and a prostaglandin which is unoprostone or latanoprost; superior intraocular pressure lowering effect |
| 09/11/2008 | US20080221171 neoplastic disease, autoimmune disease, transplantation related pathology and/or degenerative disease; selectively inducing apoptosis in cancer cells |
| 09/11/2008 | US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/11/2008 | US20080221145 Pyrroloquinoline quinone drugs for treatement of cardiac injury and methods of use thereof |
| 09/11/2008 | US20080221089 Compositions and methods for inhibition of the jak pathway |
| 09/11/2008 | US20080221087 Substituted lactams as inhibitors of abeta protein production |
| 09/11/2008 | US20080221085 Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221066 Agmatine or aminoguanidine and dextran hydroxypolymer, Tc-99m radionuclide, Farmorubicine anticancer drug, Tamoxifen; intravesically, regiolocally, peritoneally, intratumorally, systemically or intravenously administrable |
| 09/11/2008 | US20080221059 Novel treatment tool for cancer: rna interference of bcas2 |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221052 Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221044 Composition for Inhibiting the Onset of Arteriosclerosis and Inhibition Method |
| 09/11/2008 | US20080221035 For killing Group B streptococci; endopeptidase and muramidase domains |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220104 Stimulate the release of cholecystokinin and serotonin into the bloodstream using tryptophan and fatty acids; enables greater weight loss |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220021 Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
| 09/11/2008 | US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases |
| 09/11/2008 | US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties |
| 09/11/2008 | US20080220005 Comb Polymers |
| 09/11/2008 | US20080220001 Using heterocyclic sulfonamide specific to carbonic anhydrase as therapeutic tools in treatment of tumor disorders |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219973 Using antigalectin-3 immunoglobulin as therapeutic in prevention and treatment of glomerulonephritis, diabetic nephropathy and/or tissue fibrosis |
| 09/11/2008 | US20080219959 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219946 Therapeutic agent and method for ovulation disorder caused by luteinized unruptured follicle |
| 09/11/2008 | US20080219932 Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219920 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 09/10/2008 | EP1967196A1 Harmful bacterium control agent containing bacillus thuringiensis |
| 09/10/2008 | EP1967184A1 Controlled release solid preparation |
| 09/10/2008 | EP1967067A2 Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals |
| 09/10/2008 | EP1965800A2 Incontinence treatment methods |
| 09/10/2008 | EP1965797A1 Methods of reducing adverse events associated with pirfenidone therapy |
| 09/10/2008 | EP1965780A2 Substituted phenol derivatives as analgesics |
| 09/10/2008 | EP1771181B1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 09/10/2008 | EP1605954B1 A food-supplement composition suitable for promoting iron absorption |
| 09/10/2008 | EP1486501B1 Aminomethyl-substituted thiazolobenzimidazole derivative |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1392375B1 Composition and use of substances for stabilising amino acids containing sulphur |
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
| 09/10/2008 | EP1356287B1 Replication assay for detecting anti-viral substances |
| 09/10/2008 | EP1323710B1 Nitrogenous five-membered ring compounds |
| 09/10/2008 | EP1312374B1 Primrose seed extracts as sugar absorption inhibitors and process for producing the same |
| 09/10/2008 | EP1303284B1 Compositions and methods for the treatment of skin damage |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | EP1285908B1 Substituted phenylpropionic acid derivatives |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1237910B1 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1067911B1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP0986314B1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids |
| 09/10/2008 | CN101262887A Prevention and treatment of ophthalmic complications of diabetes |
| 09/10/2008 | CN101262885A Pharmaceutical compositions containing sc(Fv)2 |
| 09/10/2008 | CN101260046A Method for refining cyclobenzaprine hydrochloride |
| 09/10/2008 | CN101259230A Medicaments assembly for treating night sweating and preparation thereof |
| 09/10/2008 | CN101259224A Chinese medicine preparation for treating spontaneous perspiration and night sweating |
| 09/10/2008 | CN101259203A Mongolian medicine medical moxibustion treatment incense |
| 09/10/2008 | CN101259122A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259121A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
| 09/10/2008 | CN101259118A Application of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone as PPAR gamma agonist |
| 09/10/2008 | CN101258976A Medicinal ear pillow |